Highbridge Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Bhubaneswar, Orissa, India, established in 2015.
2015 Bhubaneswar, Orissa, India Struck Off
Last Updated:
Access Report
About Highbridge Pharmaceuticals Private Limited

Highbridge Pharmaceuticals Private Limited, a struck off private limited company, was established on 19 March 2015 in Bhubaneswar, Orissa, India. Engaging in retail trading within the trading sector, it holds CIN: U24230OR2015PTC018793. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Aruna Kumar Sarangi (Director), Bibhu Prasad Mohapatra (Director). Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Plot No.-3, Santi Vihar, Po- Baramunda, P.S- Khnadagiri, Bhubaneswar, Orissa, 751003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230OR2015PTC018793

  • Registration Number

    018793

  • Incorporation Date

    19 March 2015

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 11 Months
  • Last Filing with ROC 31 Mar 2016
Company report

Highbridge Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Highbridge Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Highbridge Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Aruna Kumar Sarangi Director 19 Mar 2015 Current
Bibhu Prasad Mohapatra Director 19 Mar 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Highbridge Pharmaceuticals.

Enhance accessibility to Highbridge Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Highbridge Pharmaceuticals revenue growth over time
Highbridge Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Highbridge Pharmaceuticals?

In 2016, Highbridge Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Highbridge Pharmaceuticals?

Unlock and access historical data on people associated with Highbridge Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Highbridge Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Highbridge Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Highbridge Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Highbridge Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Highbridge Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Cuttack. was documented.

  • Director Appointment

    Aruna Kumar Sarangi was appointed as a Director was appointed as a Director on 19 Mar 2015 & has been associated with this company since 10 years 11 months . was recorded as a recent event.

  • Director Appointment

    Bibhu Prasad Mohapatra was appointed as a Director was appointed as a Director on 19 Mar 2015 & has been associated with this company since 10 years 11 months . was recorded as a recent event.

  • Company Incorporation

    The activity Highbridge Pharmaceuticals Private Limited was registered on 19 Mar 2015 with Roc Cuttack & aged 10 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Highbridge Pharmaceuticals Private Limited?

The CIN of Highbridge Pharmaceuticals Private Limited is U24230OR2015PTC018793.

Where is Highbridge Pharmaceuticals Private Limited headquartered?

Highbridge Pharmaceuticals Private Limited is headquartered at Plot No.-3, Santi Vihar, Po- Baramunda, P.S- Khnadagiri, Bhubaneswar, Orissa, 751003.

When was Highbridge Pharmaceuticals Private Limited incorporated?

Highbridge Pharmaceuticals Private Limited was incorporated on 19 March 2015.

Who are the current directors of Highbridge Pharmaceuticals Private Limited?

The current directors of Highbridge Pharmaceuticals Private Limited are

What is the primary industry of Highbridge Pharmaceuticals Private Limited?

The primary industry of Highbridge Pharmaceuticals Private Limited is Trading.

Is Highbridge Pharmaceuticals Private Limited a listed company?

Highbridge Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Highbridge Pharmaceuticals Private Limited?

The authorized capital of Highbridge Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Highbridge Pharmaceuticals Private Limited?

The compliance status of Highbridge Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available